SMTL ID : 3l16.1

Discovery of (thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

monomer

Ligands

1 x JZX: 5-(6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)pyridin-2-amine(Non-covalent)

JZX.1: 18 residues within 4Å: Chain A: K.660, V.661, M.662, A.663, I.689, K.691, D.694, L.696, D.699, Y.725, I.737, E.738, I.739, V.740, T.745, M.811, I.821, D.822 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:I.737, A:I.821 Hydrogen bonds: A:A.663, A:D.694, A:D.694, A:V.740

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sutherlin, D.P. et al., Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer. J.Med.Chem. (2010)

Release Date

2010-02-16

Peptides

Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform

Related Entries With Identical Sequence